EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers

Pengpeng Zhang iD, Jiaqi Feng, Min Rui, Jiping Xie, Lianmin Zhang, Zhenfa Zhang iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.18516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Pengpeng Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy,…. Hauptthemen laut MEDLINE: Machine Learning, Adenocarcinoma of Lung, Biomarkers, Tumor, Single-Cell Analysis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Tianjin Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The progression of lung adenocarcinoma (LUAD) from atypical adenomatous hyperplasia (AAH) to invasive adenocarcinoma (IAC) involves a complex evolution of tumour cell clusters, the mechanisms of which remain largely unknown. By integrating single‐cell datasets and using inferCNV, we identified and analysed tumour cell clusters to explore their heterogeneity and changes in abundance throughout LUAD progression. We applied gene set variation analysis (GSVA), pseudotime analysis, scMetabolism, and Cytotrace scores to study biological functions, metabolic profiles and stemness traits. A predictive model for prognosis, based on key cluster marker genes, was developed using CoxBoost and plsRcox (CPM), and validated across multiple cohorts for its prognostic prediction capabilities, tumour microenvironment characterization, mutation landscape and immunotherapy response. We identified nine distinct tumour cell clusters, with Cluster 6 indicating an early developmental stage, high stemness and proliferative potential. The abundance of Clusters 0 and 6 increased from AAH to IAC, correlating with prognosis. The CPM model effectively distinguished prognosis in immunotherapy cohorts and predicted genomic alterations, chemotherapy drug sensitivity, and immunotherapy responsiveness. Key gene S100A16 in the CPM model was validated as an oncogene, enhancing LUAD cell proliferation, invasion and migration. The CPM model emerges as a novel biomarker for predicting prognosis and immunotherapy response in LUAD patients, with S100A16 identified as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAdenocarcinoma of LungBiomarkers, TumorSingle-Cell AnalysisDisease ProgressionLung NeoplasmsTumor MicroenvironmentHumansPrognosisGene Expression Regulation, NeoplasticImmunotherapyGene Expression Profiling

Stichwörter der Autor:innen

S100A16immunotherapy responselung adenocarcinomamachine learningsingle‐cell analysis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical Univer…
  • Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China.

ORCID-Profile: Pengpeng Zhang, Zhenfa Zhang

Förderung

  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Zhang, P., Feng, J., Rui, M., Xie, J., Zhang, L., & Zhang, Z. (2024). Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.18516

Vancouver

Zhang P, Feng J, Rui M, Xie J, Zhang L, Zhang Z. Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.18516

BibTeX
@article{Zhang2024,
  author = {Zhang, Pengpeng and Feng, Jiaqi and Rui, Min and Xie, Jiping and Zhang, Lianmin and Zhang, Zhenfa},
  title = {Integrating machine learning and single‐cell analysis to uncover lung adenocarcinoma progression and prognostic biomarkers},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.18516}
}
Kostenlos starten →